These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Is spinal muscular atrophy the result of defects in motor neuron processes? Briese M; Esmaeili B; Sattelle DB Bioessays; 2005 Sep; 27(9):946-57. PubMed ID: 16108074 [TBL] [Abstract][Full Text] [Related]
24. Temporal and tissue-specific variability of SMN protein levels in mouse models of spinal muscular atrophy. Groen EJN; Perenthaler E; Courtney NL; Jordan CY; Shorrock HK; van der Hoorn D; Huang YT; Murray LM; Viero G; Gillingwater TH Hum Mol Genet; 2018 Aug; 27(16):2851-2862. PubMed ID: 29790918 [TBL] [Abstract][Full Text] [Related]
25. Dysregulation of Mdm2 and Mdm4 alternative splicing underlies motor neuron death in spinal muscular atrophy. Van Alstyne M; Simon CM; Sardi SP; Shihabuddin LS; Mentis GZ; Pellizzoni L Genes Dev; 2018 Aug; 32(15-16):1045-1059. PubMed ID: 30012555 [TBL] [Abstract][Full Text] [Related]
26. Converging Mechanisms of p53 Activation Drive Motor Neuron Degeneration in Spinal Muscular Atrophy. Simon CM; Dai Y; Van Alstyne M; Koutsioumpa C; Pagiazitis JG; Chalif JI; Wang X; Rabinowitz JE; Henderson CE; Pellizzoni L; Mentis GZ Cell Rep; 2017 Dec; 21(13):3767-3780. PubMed ID: 29281826 [TBL] [Abstract][Full Text] [Related]
27. Disease mechanisms and therapeutic approaches in spinal muscular atrophy. Tisdale S; Pellizzoni L J Neurosci; 2015 Jun; 35(23):8691-700. PubMed ID: 26063904 [TBL] [Abstract][Full Text] [Related]
28. Spinal muscular atrophy phenotype is ameliorated in human motor neurons by SMN increase via different novel RNA therapeutic approaches. Nizzardo M; Simone C; Dametti S; Salani S; Ulzi G; Pagliarani S; Rizzo F; Frattini E; Pagani F; Bresolin N; Comi G; Corti S Sci Rep; 2015 Jun; 5():11746. PubMed ID: 26123042 [TBL] [Abstract][Full Text] [Related]
29. SMN deficiency alters Nrxn2 expression and splicing in zebrafish and mouse models of spinal muscular atrophy. See K; Yadav P; Giegerich M; Cheong PS; Graf M; Vyas H; Lee SG; Mathavan S; Fischer U; Sendtner M; Winkler C Hum Mol Genet; 2014 Apr; 23(7):1754-70. PubMed ID: 24218366 [TBL] [Abstract][Full Text] [Related]
30. Time Is Motor Neuron: Therapeutic Window and Its Correlation with Pathogenetic Mechanisms in Spinal Muscular Atrophy. Govoni A; Gagliardi D; Comi GP; Corti S Mol Neurobiol; 2018 Aug; 55(8):6307-6318. PubMed ID: 29294245 [TBL] [Abstract][Full Text] [Related]
31. Gene activation of SMN by selective disruption of lncRNA-mediated recruitment of PRC2 for the treatment of spinal muscular atrophy. Woo CJ; Maier VK; Davey R; Brennan J; Li G; Brothers J; Schwartz B; Gordo S; Kasper A; Okamoto TR; Johansson HE; Mandefro B; Sareen D; Bialek P; Chau BN; Bhat B; Bullough D; Barsoum J Proc Natl Acad Sci U S A; 2017 Feb; 114(8):E1509-E1518. PubMed ID: 28193854 [TBL] [Abstract][Full Text] [Related]
32. hnRNP M facilitates exon 7 inclusion of SMN2 pre-mRNA in spinal muscular atrophy by targeting an enhancer on exon 7. Cho S; Moon H; Loh TJ; Oh HK; Cho S; Choy HE; Song WK; Chun JS; Zheng X; Shen H Biochim Biophys Acta; 2014; 1839(4):306-15. PubMed ID: 24533984 [TBL] [Abstract][Full Text] [Related]
33. Spinal muscular atrophies reveal motor neuron vulnerability to defects in ribonucleoprotein handling. Anderson K; Talbot K Curr Opin Neurol; 2003 Oct; 16(5):595-9. PubMed ID: 14501843 [TBL] [Abstract][Full Text] [Related]
34. A transgene carrying an A2G missense mutation in the SMN gene modulates phenotypic severity in mice with severe (type I) spinal muscular atrophy. Monani UR; Pastore MT; Gavrilina TO; Jablonka S; Le TT; Andreassi C; DiCocco JM; Lorson C; Androphy EJ; Sendtner M; Podell M; Burghes AH J Cell Biol; 2003 Jan; 160(1):41-52. PubMed ID: 12515823 [TBL] [Abstract][Full Text] [Related]
35. Metabolic and Nutritional Issues Associated with Spinal Muscular Atrophy. Li YJ; Chen TH; Wu YZ; Tseng YH Nutrients; 2020 Dec; 12(12):. PubMed ID: 33339220 [TBL] [Abstract][Full Text] [Related]
38. Survival of motor neuron protein downregulates miR-9 expression in patients with spinal muscular atrophy. Wang LT; Chiou SS; Liao YM; Jong YJ; Hsu SH Kaohsiung J Med Sci; 2014 May; 30(5):229-34. PubMed ID: 24751385 [TBL] [Abstract][Full Text] [Related]
39. Loganin possesses neuroprotective properties, restores SMN protein and activates protein synthesis positive regulator Akt/mTOR in experimental models of spinal muscular atrophy. Tseng YT; Chen CS; Jong YJ; Chang FR; Lo YC Pharmacol Res; 2016 Sep; 111():58-75. PubMed ID: 27241020 [TBL] [Abstract][Full Text] [Related]